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Marek’s disease virus (MDV) is an alpha-herpesvirus causing Marek’s disease in chickens, mostly associated with T-cell
lymphoma. VP22 is a tegument protein abundantly expressed in cells during the lytic cycle, which is essential for MDV
spread in culture. Our aim was to generate a pathogenic MDV expressing a green fluorescent protein (EGFP) fused to
the N-terminus of VP22 to better decipher the role of VP22 in vivo and monitor MDV morphogenesis in tumors cells. In
culture, rRB-1B EGFP22 led to 1.6-fold smaller plaques than the parental virus. In chickens, the rRB-1B EGFP22 virus was
impaired in its ability to induce lymphoma and to spread in contact birds. The MDV genome copy number in blood
and feathers during the time course of infection indicated that rRB-1B EGFP22 reached its two major target cells, but
had a growth defect in these two tissues. Therefore, the integrity of VP22 is critical for an efficient replication in vivo, for
tumor formation and horizontal transmission. An examination of EGFP fluorescence in rRB-1B EGFP22-induced tumors
showed that about 0.1% of the cells were in lytic phase. EGFP-positive tumor cells were selected by cytometry and
analyzed for MDV morphogenesis by transmission electron microscopy. Only few particles were present per cell, and
all types of virions (except mature enveloped virions) were detected unequivocally inside tumor lymphoid cells.
These results indicate that MDV morphogenesis in tumor cells is more similar to the morphorgenesis in fibroblastic
cells in culture, albeit poorly efficient, than in feather follicle epithelial cells.Introduction
Marek’s disease virus (MDV), also referred to as Gallid
herpesvirus 2, is the causative agent of Marek’s disease
(MD) in chicken, a multifaceted disease most widely
recognized by the induction of a rapid and extensive ma-
lignant T-cell lymphoma. MDV is a type-species of the
Mardivirus genus (Marek’s disease-like viruses) within
the Alphaherpesvirinae subfamily of the Herpesviridae
family. The actual MD physiopathology model was ori-
ginally proposed by Calnek (reviewed in [1,2]). Upon
entry via the respiratory tract associated with the inhalation
of infectious dusts or danders, MDV first replicates in B
lymphocytes and subsequently in activated T lymphocytes,* Correspondence: denesvre@tours.inra.fr
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reproduction in any medium, provided the orleading to acute cytolysis. About 7 days post-infection
(dpi), the virus enters a latent state in a subset of CD4+ T
cells, which may become transformed leading to lymph-
oma lesions and mortality, with high rates in genetically
susceptible animals (90-100%). Tumors are predominantly
located in visceral organs, but also in muscles and skin.
Early after infection, the virus is presumably transported by
infected lymphocytes to the skin, where it replicates in
feather follicles epithelium (FFE) and is shed into the
environment [3]. Viral genomes are usually detectable by
quantitative PCR (qPCR) in blood cells and feather tips
in the first week post-infection at 4–7 dpi with virulent
and vaccinal strains, and reach higher levels after 10–21
dpi [4-7].
For more than forty years, it has been recognized that
MD tumors are a source of infectious MDV when inocu-
lated into recipient chickens. However, MDV particlestd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tissue (reviewed in [8]); when found, MDV particles
were only in a very low number of cells from lympho-
blastoid or epithelial origin [9-12]. In these studies,
mostly kidney and gonad tumors were analyzed. It is
also noticeable that in lymphoblastoid cells from tumors,
MDV particles were only observed in the nucleus as naked
nucleocapsids or in the perinuclear region as primary-
enveloped virions. In such cells, MDV virions were never
observed in the cytoplasm as expected in the double en-
velopment morphogenesis model [13-15]). In that model,
the assembly process begins in the nucleus where the viral
genome is packaged into capsids, resulting in type C cap-
sids. Then, nucleocapsids exit the nucleus, by budding into
the inner membrane of the nuclear envelope as primary-
enveloped virions. Next, these virions fuse with the nu-
clear outer membrane, resulting in the release of capsids
in the cytoplasm. Finally, the cytosolic capsids bind several
tegument proteins and are re-enveloped by budding into
cytoplasmic vesicles, resulting in mature virions, which
exit from the cell, probably by exocytosis.
The VP22 protein encoded by UL49 gene is specific to
alpha-herpesviruses. This 249 to 304 amino acid protein
is a major constituent of the virus tegument layer. In
culture, UL49 functional requirements vary by type of
alpha-herpesvirus and by host cell. The UL49 gene has
been shown to be absolutely necessary for the replication
of MDV and VZV [16-18] whereas UL49 is dispensable
for Pseudorabies virus (PRV), Herpes Simplex type 1
(HSV1), and Bovine Herpes virus type 1 (BoHV1) [19-22].
In BoHV1, the deletion of UL49 reduced extracellular
virus titers of about 10-fold [23] and plaques size in
MDBK by 52% [21]. In HSV-1, the absence of UL49 im-
paired virus growth in MDBK, but not in Vero cells [20].
In vivo, UL49 was found to play a role in the virulence of
BoHV1 in cattle and HSV1 in mice, [22,24,25], but was
not involved in the virulence of PRV in rodents [19]. We
have previously shown that an attenuated recombinant
MDV (Bac20) expressing a EGFP fused in the N-terminus
(N-term) of VP22 had a 3-fold decrease in plaques size
in cell culture [26]. A recombinant MDV expressing a
EGFP fused in the C-terminus (C-term) of VP22 in the
very virulent RB-1B pathogenic background was recently
reported to be highly attenuated, inducing tumors in
only 10% of injected chickens [27]. Herein, we constructed
a new EGFP-UL49 recombinant MDV in the RB-1B
pathogenic background, in which the fluorescent tag was
fused in 5′ of the UL49 gene, and investigated its pheno-
type in susceptible chickens in order to better characterize
the role of VP22 in MD pathogenesis. We showed an at-
tenuation in tumor formation by 1.5 to 3-fold, horizontal
transmission and virus replication in vivo. Electron micro-
scopic examination of MD tumors expressing EGFP pro-




Chicken embryonic skin cells (CESCs) were prepared
and cultivated as previously described [28] from 12-day
chicken embryos (LD1 Brown Leghorn chicken line). The
RB-1B bacmid used in this study corresponds to the
repaired Bac RB-1B 1272 [6]. This bacmid was kindly
provided by Dr K. Osterrieder.
Generation of the recombinant rRB-1B EGFP22 bacmid and
virus expressing the MDV VP22 fused to EGFP in N-term
The Bac RB-1B EGFP22 was generated by “en passant
mutagenesis” method [29]. Briefly, for the first recombin-
ation step, we used the p48-50 shuttle plasmid schematic-
ally represented in Figure 1A, resulting from the insertion
in StuI of the Stu-ISceIKana-Stu cassette (1047 bp) into
the p48-50 StuNhe EGFPUL49 (previously described in
[26,30]). In that last plasmid, the UL48-50 region origi-
nated from the RB-1B strain. The first recombination was
obtained after transformation of GS1783 bacteria contain-
ing the RB-1B 1272 bacmid with the 3489-bp XmnI/HpaI
restriction fragment from the shuttle plasmid and kanamy-
cin selection. The second recombination was obtained after
inducing the I-SceI expression in order to excise the
kanamycin-resistance cassette. After the second recombin-
ation step, the mutant bacmid was verified by sequencing
the entire region between HpaI and XmnI restriction sites
(2442 bp) at 5′ and 3′ ends of EGFPUL49, in which the
two recombinations occurred.
The generation of the rRB-1B EGFP22 virus was ob-
tained as follows: 4 × 106 CESCs were transfected with
6 μg of the mutant bacmid by using the calcium phos-
phate method. Six days later, the cell monolayer show-
ing fluorescent viral plaques was harvested and the
virus was amplified by replication on fresh CESCs. In
this study, the virus used never exceeded 4 passages in
CESCs.
Detection of VP22 proteins expression by immunoblotting
VP22 was detected in Western-blot either by using an
anti-GFP antibody or the L13a MDV VP22 specific
antibody as previously described [26] with a few modi-
fications listed below: The infected or non-infected cell
monolayers were trypsinized, pelleted, and resuspended
in lysis buffer (50 mM NaCl, 0.5 mM DTT, 0.5 mM
MgCl2, 2.5 mM Tris HCl pH 8, 0.5% NP40 supple-
mented with benzonase (25 UI/mL) (Novagen-EMD
Biosciences, Billerica, Mass, USA) and protease inhibi-
tors (complete mini EDTA-free, Roche Applied science,
Penzberg, Germany) and incubated 1 h 30 at 4 °C. The
lysate was centrifugated 30 min at 4 °C at 15 600 g. The
Figure 1 Construction and characterization of rRB-1B EGFP22 in cell culture. A. Schematic representation of the shuttle plasmid constructed
to generate the rRB-1B EGFP22 mutant by using homologous recombination in E. coli with the pRB-1B 1272 DNA bacmid. The shuttle plasmid
was derived from the p48-50 StuNhe EGFPUL49 plasmid previously described. B. Analysis of EGFP expression by fluorescence. Picture of an infection
plaque visualized with EGFP fluorescence at 5 dpi (low magnification). At high magnification, infected cells were stained with an anti-VP5 capsid mouse
MAb (red) and Hoechst 33342 dye, staining nuclei (blue). C. Flow cytometry analysis on CESCs infected with rRB-1B EGFP22 (green curve) or non-infected
(black curve), based on EGFP fluorescence. In this experiment, about 20% of the rRB-1B EGFP22 infected cells were EGFP-positive. D. Analysis of EGFPVP22
protein expression in infected cells by immunoblot revealed with an anti-GFP or an anti-MDV VP22 antibody. The stars indicate either the EGFPVP22 or
the VP22. An anti-VP5 antibody was used as a control. Mock corresponds to non-infected cells. E. Plaques size comparison. At 5 dpi, 50 plaques were
stained with a cocktail of anti-MDV antibodies followed by a secondary antibody coupled to Alexafluor 594. Plaques were photographed with the cell
observer system (Zeiss, Göttingen, Germany) on the red channel, and measured using the Axiovision software. The error bars represent the standard error
of the mean (SEM) of the size of 50 plaques; the values on the graph indicate the plaque size ratio between rRB-1B and rRB-1B EGFP22 (***, P< 0.0001).
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2 × Laemmli sample buffer and boiled. Solubilized pro-
teins were separated by SDS-PAGE. For the rabbit poly-
clonal anti-GFP antibody (Clontech, Mountain view, CA,USA), the staining was performed as previously described
[26]. For the L13a anti-VP22 mouse monoclonal antibody
(MAb), the incubations were performed in Tris NaCl
pH 8.25 instead of Tris NaCl pH 7.5.
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CESCs (1.5 × 106) grown on 6-well plates were infected
with 100 plaque-forming units (pfu) of recombinant
rRB-1B 1272 (parental) or rRB-1B EGFP22 (mutant) vi-
ruses. At 5 dpi, cell monolayers were fixed with 4% para-
formaldehyde (PFA) and plaques were stained with a
cocktail of three monoclonal antibodies as previously de-
scribed [31]. The plaques were observed with a Fluar × 5
objective mounted on an Axiovert 200 M inverted epi-
fluorescence microscope (Zeiss, Göttingen, Germany),
photographed with a CCD camera, and measured and ana-
lyzed as previously described [32].In vivo experiments
Specific pathogen-free White Leghorn chicks (B13/B13
haplotype) were housed in isolation units. Chicks were
inoculated intramuscularly (pectoral muscles) with 1000
(experiment 1) or 1500 pfu (experiment 2) of each virus
(rRB-1B EGFP22 mutant or rRB-1B parental) at 1 week
of age. Birds were evaluated daily for MD symptoms, eu-
thanized, and necropsied when they presented clinical
evidence of MD. At the end of the experiments, all surviv-
ing birds had their blood sampled, and were euthanized
and necropsied. In experiment 1, 12 inoculated birds were
housed with 9 or 11 naive birds (contacts) from the begin-
ning of the experiment in order to monitor MDV spread
into contacts. Injected and contact surviving birds were
euthanized at 90 and between 112–130 dpi, respectively.
In experiment 2, 12 inoculated chicks per group were
housed in order to measure the viral load in blood and
feather tips during the course of the infection. Infected
surviving birds were euthanized at 105 dpi. Blood samples
(50 μL) from all birds were collected in sodium citrate
75 mM (vol:vol) before infection and at 7, 14, 21, 28,
36 dpi. In addition, 8 axillary tract feathers were collected
as described [33] from 10 birds before infection, and at 13,
27, 35 dpi on all birds. After 36 dpi, blood and feather
samples were collected only from surviving birds in the
rRB-1B EGFP22 group. In addition, blood (5 mL) was col-
lected from the 7 surviving birds in the rRB-1B EGFP22
group at the end of the experiment (105 dpi) for per-
ipheral blood mononuclear cells (PBMCs) preparation.
PBMCs were prepared as follows: 10 mL of chicken blood
(diluted at 1:2 in phosphate buffer solution [PBS]) was
loaded over 5 mL of MSL (medium for lymphocytes isola-
tion, Eurobio, Les Ulis, France). After centrifugation at
2200 rpm for 20 min, PBMCs were collected at the inter-
face plasma/MSL, rinsed twice in PBS, and used for virus
isolation on CESCs.
All experimental procedures were conducted with good
animal practice and approved by the appropriate local ethic
committee ("Comité Régional d'Ethique pour l'Expérimen-
tation Animale", CREEA, protocol number #CL207-40).DNA extraction from whole blood and feathers tips
Thirty microliters of blood-citrate was mixed with 1 mL
of a cold permeabilizing solution (10% saccharose (w/v),
10 mM Tris HCl 7.5, 5 mM MgCl2, 1% Triton X-100) and
immediately centrifuged 5 min at 1100 g to remove
hemoglobin. The pellet was next resuspended in 500 μL of
lysis buffer (10 mM Tris HCl pH 8, 10 mM NaCl, 10 mM
EDTA, and 1 mg/mL proteinase K) and digested overnight
at 56 °C. After an extraction with phenol-chloroform,
DNA was precipitated with ethanol. Final DNA was eluted
in 25 to 100 μL of ultrapure water supplemented with
RNAse A at 10 μg/mL (Sigma, St Louis, MO, USA).
For each animal, the pulp and the epithelium of the
collected feather tips was extracted mechanically on a
small piece of Whatman paper. All samples were harvested
individually, except at time 0 at which extractions were
performed in two pools. For DNA extraction, the What-
man paper was soaked in 500 μL of lysis buffer (10 mM
Tris HCl pH 8, 0.5% SDS, 0.5 mg/mL proteinase K) over-
night at 56 °C. The following steps of the DNA extraction
were performed as for the blood (described above).
Quantification of MDV genome copies by qPCR
Quantification of MDV genome copies using qPCR was
performed using the TaqMan technology, as previously
described by Jarosinski et al. [6,34]. Primers and probes
sequences (reported in [34]) were obtained from Euro-
gentec. The iNos and the ICP4 probes were tagged with
FAM-BHQ1 and Yakima Yellow-BHQ1, respectively. Each
qPCR mixture contained 10 μL of 2 × Fast Blue qPCR mas-
ter mix (Eurogentec, Seraing, Belgium), 9.5 μL of diluted
DNA, 10 pmol of each gene-specific primer, 5 pmol of the
gene-specific probe in a 20 μL volume. ICP4 and iNos
genes were quantified independently on triplicates. The
standard curve for ICP4 was obtained by performing qPCR
on a serial 10-fold dilution of a bacmid containing the en-
tire MDV genome (Bac20) starting at 4.75 ng (23.1 × 106
copies). The standard curve for iNos was performed in the
same manner, starting from 475 pg (56.8 × 106 copies) of a
pBS iNos plasmid. The positive cut-off points corres-
pond to ≥ 23 and 57 copies of viral DNA and iNos,
according to the standard curves. All qPCR were per-
formed in a Dyad Disciple chromo 4 apparatus (BioRad,
Marnes-la-Coquette, France) and the results were analyzed
using the MJ opticon monitor software (version 3.1)
(BioRad). For each sample, the number of MDV genome
copies per 106 cells was calculated based on the number of
ICP4 copies per 106 iNos copies.
Sorting of EGFP-positive cells by flow cytometry from MD
tumors developed by rRB-1B EGFP22-infected chickens
Tumors from different organs (gonads, kidneys, or spleen)
were collected freshly after chicken death into a large vol-
ume of RPMI medium, cut into 1-cm3 pieces, rinsed twice
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dissociation, tumor cell suspension was resuspended into
20 mL of PBS and overlaid on 10 mL of MSL (see above).
After centrifugation, the cells at the inferface were har-
vested, rinsed twice in 15 mL of EMEM. An aliquot of each
cell preparation was taken for analysis by fluorescence mi-
croscopy. Cells were fixed with 4% PFA for 1 h at room
temperature, and subsequently mixed with 1 volume of
PBS, and stored at 4 °C until cell sorting, 1 to 4 days after
fixation. Just before sorting, cells were resuspended and fil-
tered on a 30-μm pore-size membrane. EGFP-positive cells
were then sorted with a MoFlo (DakoCytomation A/S, Fort
Collins, USA) high-speed cell sorter as previously de-
scribed [26]. The only difference was the purification mode
which was enriched, a mode that does not eliminate dou-
blets of positive and negative cell, and allow the purifica-
tion of more EGFP-positive cells than with the “purified
mode”, but with a lower purity. The enriched mode was
chosen because of the low percentage of EGFP-positive
cells, in order to not lose positive cells. The sorted cells
were collected in 4% PFA for all purposes.
Fluorescence microscopy
MDV infected cells in culture
CESCs grown on coverslips were infected with the rRB-1B
EGFP22 or the parental virus with 100 pfu and fixed 5 dpi
with 4% PFA. Cells were then stained with an anti-MDV
VP5 monoclonal antibody as previously described [26] and
observed on an Axiovert 200 M inverted epi-fluorescence
microscope equipped with a 40× PlanNeofluar oil/Dic ob-
jective or a 63× PlanApochromat oil/DIC, both with the
ApoTome system (Zeiss). Images were captured with a
CCD Axiocam MRm camera (Zeiss) using the Axiovision
software (Zeiss).
Explanted tumor cells
EGFP-sorted and non-sorted tumor cells were centri-
fuged at low speed with a cytospin (Shandon Southern)
on a 0.17-μm glass coverslip coated with poly-L-lysine
solution (Sigma-Aldrich, St Louis, Mo, USA), fixed and
stained with Hoechst 33342 before observation by fluor-
escence microscopy as described above. Cells from one
tumor were stained with an antibody anti-chicken CD4
(clone CT-4, Southern biotech, Birmingham, AL, USA)
followed by a donkey anti-mouse IgG Texas red (Jacskon
laboratory, Bar Harbor, ME, USA).
Transmission electron microscopy (TEM)
Approximately 38 000 EGFP-enriched cells derived from
a rRB-1B EGFP22-induced tumor (Testis #16) were pel-
leted and prepared as previously described for TEM
[35]. Ultrathin sections (100-nm thick) were cut, placed
on EM grids, and stained with 5% uranyl acetate plus 5%
lead citrate. All sections were observed either with a Jeol1011 or a Jeol 1230 microscope (JEOL, Tokyo, Japan)
equipped with a ES1000W Erlangshen CDD Camera
(Gatan, Pleasanton, Calif.). Images were captured through
Digital Micrograph software version 3.11.1 (Gatan).
Results
Generation of rRB-1B EGFP22 MDV
We inserted and fused the EGFP sequence in 5′ of the
UL49 gene in the context of the repaired pathogenic
rRB-1B bacmid, as schematized in Figure 1A. The mu-
tated bacmid, Bac RB-1B EGFP22, was verified by se-
quencing the complete region between the XmnI/HpaI
restriction sites (2442 bp) (Figure 1A). A viral progeny
obtained after transfection into CESCs was amplified
and its phenotype was analyzed in cell culture. The
EGFP signal appeared in cells expressing other late anti-
gens like VP5 capsid protein, indicating a lytic infection
(Figure 1B). The EGFP signal was intense and allowed
an easy detection of infected cells by microscopy or cy-
tometry (Figure 1B and C), on live or PFA-fixed cells.
The apparent molecular mass of the tagged EGFPVP22
protein appeared as a doublet in Western-blot, with a
major form of about 50 kDa (Figure 1D), as previously
shown in another MDV genetic background [26]. In
addition, the rRB-1B EGFP22 virus showed a reduction
in cell-to-cell spread, with a significant 1.5- to 1.7-fold
decrease in plaques size compared with the parental virus
(as measured in two independent experiments; P < 0.0001;
Figure 1E).
Comparison of rRB-1B EGFP22 with rRB-1B parental virus
regarding lymphoma formation and horizontal
dissemination in chickens
In order to evaluate the phenotype of the rRB-1B
EGFP22 virus in vivo, 1 week-old MD-susceptible B13/
B13 White Leghorn chicks were inoculated intramus-
cularly with 1000 pfu of the rRB-1B EGFP22 or the
parental virus. rRB-1B EGFP22 and rRB-1B induced tu-
mors in 66% and 83% of the inoculated birds (P < 0.05;
Fisher’s exact test), respectively, with a mean time to dis-
ease onset of 59 and 36 dpi, respectively (P < 0.05; Mann–
Whitney U test) (Figure 2A). Moreover, in both groups
33% of the inoculated birds had tumors in three or more
organs, suggesting that tumors-induced by both vi-
ruses presented no difference in their ability to spread
to multiple organs (defined herein as aggressiveness)
(Figure 2B). All together, these results indicated that
the rRB-1B EGFP22 virus is partially attenuated in its
efficiency to induce lymphoma, but not in its tumor
aggressiveness.
The incidence of MD was also evaluated in contact
birds (Figure 2A). At the end of the experiment, 78% of
the contacts in the rRB-1B group developed tumors
while only 36% did in the rRB-1B EGFP22 group. In
Figure 2 MD incidence and tumor formation in chickens infected with the rRB-1B EGFP22 virus. A. Cumulative incidence of MD in birds
inoculated with rRB-1B EGFP22 or rRB-1B viruses (n = 12), and contact naive birds of the same age (n = 9 to 11) housed together (Experiment 1).
Viruses (1000 pfu) were inoculated intramuscularly into groups of 1 week-old, B13/B13 White Leghorn chickens. MD incidence was determined by
identification of gross lesions at the necropsy. In both groups, at the end of the experiment, a few chickens showing no clinical signs had tumors.
The cumulative incidence of the disease is expressed as a percentage. B. Lymphoma incidence in inoculated birds of each group, according to
the number of organs presenting macroscopic MD lesions in each bird.
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out of the 7 surviving birds presented MDV antibody
seroconversion, suggesting that most surviving con-
tact birds were not infected (not shown). These results
showed that the rRB1B EGFP22 is impaired in bird-to-birddissemination compared with the rRB-1B virus. This
suggests that the mutant virus is either weakly shed
from the inoculated birds, less stable in the environment,
and/or less infectious by the respiratory route than the
parental virus.
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rRB-1B EGFP22 and rRB-1B
In order to explore whether the lower tumorigenicity in
inoculated birds and the lower transmission to contact
birds of rRB-1B EGFP22 was associated with a decrease
in viral replication in lymphocytes and feather follicles,
we performed a second in vivo experiment in which we
measured MDV genome copy number by real-time
qPCR in whole blood and feather tips of injected birds.
In this experiment, the chickens received a higher dose
of virus inoculum (1500 pfu in Expt 2 vs 1000 pfu in
Expt 1) in order to determine whether a higher dose
would increase MD incidence in the rRB-1B EGFP
group. The rRB-1B EGFP22 and rRB-1B viruses induced
tumors in 33% and 100% of the injected birds, respect-
ively confirming that the rRB-1B EGFP22 virus is attenu-
ated in its ability to induce lymphoma. Surprisingly,
increasing the rRB-1B EGFP inoculum dose did not
increase MD incidence, but had even a contrary effect.
The difference in tumor incidence between the two ex-
periments could not be attributed to the inoculum, as
the same viral stock was used in both experiments.
DNA samples were prepared from blood or axillary
feather tips at various time points in both groups. DNA
was extracted individually (except for feathers at time 0)
and analyzed for the ICP4 viral gene and iNOS cellular
gene by qPCR using the TaqMan technology. MDV gen-
ome copy number per million cells was determined by
using standard curves for ICP4 and iNOS. In the rRB-1B
group, the MDV genome was detectable in the blood of
all infected birds examined until 36 dpi, except at 7 dpi
(90.3% ICP4 positive samples, n = 52) (Figure 3A). Most
of viral loads measured were between 103 and 106 gen-
ome copies per million blood cells (Figure 3B). The
mean of the viral load increased progressively over time
to reach 1.8 × 105 at 36 dpi.
In the rRB-1B EGFP22 group, MDV DNA was de-
tectable in 67% of the blood samples analyzed between
14 and 36 dpi (n = 33) (Figure 3A). The MDV genome
was undetectable in the blood at 7 dpi, suggesting a
delay in replication. All birds except one were found
positive for the virus at least once. The viral loads mea-
sured in the positive blood samples were usually be-
tween 103 and 105 viral DNA copies per million cells
(Figure 3B). When rRB-1B EGFP22 was detectable, the
mean viral load was about 2- to 20-fold lower than in
the rRB-1B group (1.8, 1.6, 26.0, and 7.3-fold lower at
14, 21, 28 and 36 dpi, respectively). In addition, rRB-1B
EGFP22 mean viral loads did not progressively increase
over time as rRB-1B mean viral loads did, suggesting
that rRB-1B EGFP22 might be better controlled by the
host. All together, these results indicate that rRB-1B
EGFP22 is delayed in its replication in blood cells by at
least 7 days, and displayed lower viral loads at all timepoints during the course of infection compared with
the rRB-1B.
In the feather tips, the MDV genome was detectable
by qPCR in 89.6% and 85.0% of the samples tested
for rRB-1B and rRB-1B EGFP22 group, respectively
(Figure 3C). At 2 week pi, 80% of the rRB-1B EGFP22-
injected chickens were ICP4-positive in feathers whereas
only 28% were in blood. The lower detection in blood
is compatible with the fact that blood contains a small
fraction of infectable cells, lymphocytes being less than
0.5% of nucleated blood cells. In the rRB-1B group,
the mean viral load was above 106 genome copies per
million cells at all time points. The mean viral loads were
35- to 52-fold lower in the rRB-1B EGFP22 group in this
tissue (Figure 3D). These differences were significant at
27 and 35 dpi between the two groups (Mann–Whitney;
P < 0.001).
Infectious rRB-1B EGFP22 virus was re-isolated from
the PBMCs of all surviving birds, after one (6/7 birds)
or two passages (1/7 bird) on CESCs in culture (not
shown), including in the bird which was always negative
by PCR on blood. This result indicates that the rRB-1B
EGFP22 genome was present in the PBMCs of all surviv-
ing birds, probably in a latent state and able to reactivate
in culture.
A small percentage of EGFPVP22 expressing cells are
present and purifiable from rRB-1B EGFP22-induced tumors
A fluorescent tag fused to a viral gene is a valuable tool
to detect herpesvirus infected cells in tissues, especially
in those containing a low number of infected cells [36].
Herein, with the tag fused to a major MDV tegument
protein, we could expect to observe a fluorescent signal
only in cells which are in lytic phase, either after neoin-
fection or reactivation from latency. Lymphoid cells
from four rRB-1B EGFP22-induced tumors originating
from three birds and three organs (kidney, testis and
spleen) were isolated on a lymphocytes separation medium
cushion and analyzed by fluorescence microscopy and flow
cytometry, without any cultivation step. A low number
of EGFP-positive cells were easily detectable among the
tumor cells by both techniques (Figures 4A and B). In flow
cytometry, this percentage was estimated between 0.07%
and 0.14% in the four tumors (Figure 4B). Examination of
the non-sorted cells from the testis tumor showed that
most cells (including the EGFP-positive cell) were CD4-
positive, with high or low level (Figure 4C). Sorted-cells
from the two kidney tumors were re-examined in fluor-
escence microscopy in order to verify the purity level
(Figure 4A). More than 60% of the cells were EGFP-
positive after sorting, showing that this procedure allows
an efficient enrichment. In these cells, the EGFP signal
was localized mostly in the cytoplasm (Figure 4). Most
of the cells had a round shape with a small diameter of
Figure 3 MDV genome copy number in blood cells and feather tips of chickens. The rRB-1B EGFP22 or rRB-1B virus (1500 pfu) was inoculated
intramuscularly in 1 week-old White Leghorn B13/B13 chickens (Experiment 2). Wing vein blood and axillary tract feathers were collected at different
times post-infection. For all samples, DNA was extracted and examined for ICP4 and iNos by qPCR. A. % of ICP4-positive chickens after blood examination
by qPCR over time. B. Viral loads (MDV genome copy number per million cells) in blood per chicken during the course of infection, with means curves
for ICP4-positive birds. C. % of ICP4-positive chickens after feather tips examination by qPCR over time. D. Mean ± SEM viral loads in feather tips per group
over time.
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http://www.veterinaryresearch.org/content/44/1/1257–8 μm, a high nucleus/cytoplasm ratio and a peripheral
ring of cortical actin (not shown), indicating that the cells
purified have a morphology compatible with the lymphoid
lineage. However the presence of few cells from other line-
ages could not be totally excluded. These results show that
a low proportion of tumor cells expressed EGFPVP22, a
marker for the lytic phase and that these cells are purifi-
able by flow cytometry.
MDV particles are present in EGFPVP22-enriched cells
isolated from tumors
In order to examine whether MDV particles could be
detected at an ultrastructural level in rRB-1B EGFP22-
induced tumors, 38 000 EGFPVP22-enriched cells from
the tumor testis (#16) (Figure 4B) were prepared for
TEM. The number of cells per grid was modest, with
about 20–25 cells per section. At low magnification,
most of the cells had a morphology compatible with an im-
mature lymphocyte (Figures 5A-D), regardless of whether
they contained viral particles or not. Rare cells had a
morphology reminiscent of an epithelial cell (Figure 5B).
When MDV particles were present, the number of parti-
cles per cell section was low, under ten (Figure 5D). Alltypes of particles were unequivocally observed at least once
over the different cell sections examined, except mature
enveloped virions (Figures 5D-I). Nuclear capsids pre-
dominated over cytoplasmic capsids. Accumulation of
perinuclear virions was only observed once (Figure 5G).
Among cytoplasmic naked capsids, we observed type C
capsids, but also A and B capsids (Figures 5E-F, I). One
cytoplasmic particle possibly enveloped, of about 220 nm
in diameter, was observed which was devoid of tegument
(Figure 5H). The number of cells presenting particles being
inferior to fifty (probably due to the loss of material in the
preparation), a quantitative MDV morphogenesis study
could not been performed. Overall, these results show that
rRB-1B EGFP22-induced tumor cells present MDV parti-
cles, including cytoplasmic particles in low numbers.
Discussion
Our work provides two important findings that contrib-
ute to a better understanding of MDV pathogenesis and
morphogenesis. First, we have shown that fusing EGFP
to the N-term of VP22 in a pathogenic RB-1B back-
ground leads to a partially attenuated virus in vivo. This
virus provides a basis for understanding the role of VP22
Figure 4 EGFP fluorescent cells in rRB-1B EGFP22-induced tumors and selection by cell-sorting. A. Microscopy analysis of tumor cells with
or without cell-sorting on the basis of EGFP fluorescence. Tumor cells, purified on MSL, were attached to glass coverslips by cytospin, stained by
Hoechst 33342 dye (blue) and analyzed by fluorescence microscopy for EGFP signal and labelled nuclei. Cells from four different tumors are
presented without cell-sorting. Cells from kidney #21 and #74 are presented with cell-sorting demonstrating the enrichment in EGFP-positive
cells. Bars represent 10 μm. B. Flow cytometry analysis of tumor cells from four different rRB-RB EGFP22-induced tumors, after MSL purification. The
percentage of EGFP-positive cells in each cell preparation is indicated on each FL1/SSC graph. C. Cells from a tumor (testis #16), without cell sorting,
examined after CD4 antibody staining for CD4 and EGFP signal.
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http://www.veterinaryresearch.org/content/44/1/125in replication and spread in its natural target cells, as
well as in lymphoma formation. It provides an interest-
ing tool for studying the relationship between the level
of virus replication and the pathogenesis. Second, we
have demonstrated that this virus allows the detection,
quantitation and purification of MD tumor cells in lytic
cycle, which has never been reported before. We exploitedthis feature in order to explore MDV morphogenesis in
such cells and showed for the first time the presence of
cytoplasmic particles supporting a complete morpho-
genesis process in these cells. Therefore, our work also
highlights the utility of MDV virus expressing a bright
fluorescent tag to trace lytically infected cells in chicken
MD tumors.
Figure 5 MDV particles in rRB-1B EGFP22 induced tumor cells examined by TEM. EGFP-positive cells were enriched from the rRB-1B
EGFP22-induced testis tumor (#16). A, B, C. Morphology of sorted-tumor cells presenting herpesvirus particles. D. Overview of a cell producing
virions, showing different types of particles. E. Enlargement of zone 1, drawn in (D), showing two types of naked capsids (type A and C) in the
nucleus near the inner nuclear membrane. F. Enlargement of zone 2, drawn in (D), showing two naked capsids (type A and C) in the cytoplasm
near a mitochondrion. G, H, I. Different types of enveloped or atypical particles. G. Vacuole or an invagination in the nucleus containing primary
enveloped virions. H. A cytoplasmic particle in a vesicle. I. Atypical cytoplasmic particle consisting of a B capsid surrounded with a large electron
dense material and a membrane. Cy, cytoplasm; Nu, nucleus. Black triangle, type A capsid; white triangle, type B capsid; white triangle with a black
outline, type C capsid.
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http://www.veterinaryresearch.org/content/44/1/125Although VP22 is known to be mandatory in MDV rep-
lication in cell culture, unlike for most alpha-herpesviruses
except VZV [16-18] the reason of VP22 essential role
in MDV biology remains unknown. Fusing EGFP tag in
N-term of VP22 in the context of RB-1B genome led to a
virus showing a spread defect of 1.6-fold in CESCs in cul-
ture. This is in accordance with our previous report in theBac20 genetic background [26], even if in the RB-1B the
tagging led to a less pronounced effect. The origin of this
attenuation is unclear as EGFPVP22 exhibits a subcellular
location similar to non-tagged VP22 after antibody stain-
ing (not shown). Although the region of VP22 between
amino acids 16 and 37 was found to be necessary for its
DNA-binding activity in vitro [28], no data had so far
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tion. The GFP tag in itself may have contributed to VP22
defect, as the GFP protein, in fusion or not, has been re-
ported to aggregate at high concentration [37]. Moreover,
we cannot totally exclude a cis effect of EGFP insertion on
the expression of the genes adjacent to UL49, like UL49.5
which is essential for MDV replication [38].
We observed that the rRB-1B EGFP22 virus induces
33 to 66% of tumors in injected and contact animals. In
comparison, the rRB-1B mutant expressing the VP22
fused to EGFP in C-term induced 10% of tumors in
injected chickens and none in contact birds [27]. There-
fore, the present study confirms that fusing a EGFP tag
to the VP22 reduces MDV lymphoma formation. How-
ever, this mutant appears less attenuated than the mu-
tant with the tag in C-term, suggesting that the tag
position may differentially affect the tumorigenicity. This
assumption should be confirmed in the future by evalu-
ating the two mutants side-by-side in chickens.
If VP22 affects tumor incidence, one important question
that remains is how VP22 acts on MDV tumorigenesis.
In particular, is VP22 directly involved in the tumori-
genesis process in T-lymphocytes or is VP22 indirectly
involved, due to a lower infectivity or viral replication
in T-lymphocytes. Indeed, Calnek proposed that the trans-
formation process is a relatively rare event governed by a
set of probabilities, and that the more transformable
targets become infected the greater the likelihood that a
successful transformation will occur [2]. In the present
study, the indirect involvement of VP22 in pathogenesis
is supported by the rRB-1B EGFP22 phenotype (a delayed
onset of lytic infection and a lower MDV load in the
blood), although the alternative hypothesis cannot be to-
tally ruled out.
By monitoring the development of MD tumors in con-
tact chickens, we showed that rRB-1B EGFP22 has a
limited horizontal spread in chickens. Moreover, the
viral load in the feathers of injected chickens was 1 to 2
log lower in the rRB-1B EGFP22 group compared with
the parental group. In this last group, the viral loads in
feather tips were in accordance with a previous report
[5]. These results indicate that rRB-1B EGFP22 reached
the feather follicles and that its skin tropism was not
altered, although its replication in feathers is reduced as
in blood cells. The growth defect of the rRB-1B EGFP22
virus is therefore general to all cell lineages tested.
We demonstrated that rRB-1B EGFP22 can be employed
to quantify and purify tumor cells in lytic cycle directly
from tumors. Although it is partially attenuated for MD
pathogenesis in chickens, rRB-1B EGFP22 is, to our know-
ledge, the only fluorescent virus efficient for such purpose.
Indeed, with the rRB-1B UL47EGFP virus, which is not at-
tenuated in vivo, the authors failed to detect fluorescent
cells from tumors (see Figure six in [27]). rRB-1B EGFP22yielded a small proportion (0.15%) of the tumors cells ex-
pressing EGFPVP22 which is compatible with previous
analyses showing that most tumor cells are latently in-
fected, and that none to very few express lytic antigens
[9,39]. Futhermore, if EGFPVP22 expression in lymphomas
reflects MDV reactivation, the fact that we observed a low
percentage of EGFPVP22-positive cells in our study like
with wild-type virus suggests that the rRB-1B EGFP22 mu-
tant is not impaired in the reactivation process.
In this report, by coupling the use of a fluorescent
MDV mutant with cell-sorting and TEM, we easily ob-
served the presence of MDV particles in a MD testis
tumor. This result is remarkable because, since MDV
discovery in 1967, most researchers have failed to detect
MDV particles in tumors [40-42] or only after extensive
study of a high number of tumors [11]. Herein, only one
tumor was examined and was found positive for MDV
particles, indicating that our approach is technically
possible and efficient in order to study MDV morpho-
genesis in tumors and potentially in other tissues or
organs. It is noticeable that the number of particles
per cell section observed in tumor cells (between one
to ten) was lower than in CESCs infected with Bac20
EGFPVP22 in culture [26]. In our opinion, the low per-
centage of cells detected during the lytic cycle in tumors
and the low number of particles per cell section is suffi-
cient to explain the difficulty to detect MDV virions in
MD tumors after direct examination by TEM. It is also
remarkable that most cells selected from MD tumors
that we observed, with or without particles (not shown),
had an ultrastructure comparable to the one previously
reported [40].
This report provides the first images of MDV particles
in the cytoplasm of lymphoid cells directly from a MD
tumor. Even though we did not examine enough cells to
perform a reliable quantitative study, cytoplasmic cap-
sids were beyond doubt in minority compared with nu-
clear particles, as previously observed in cell culture. In
addition, the three types of naked capsids (A, B, and C)
were visualized in the cytoplasm of cells in which the
nuclear envelopes were not disrupted, which is unusual
for an alphaherpesvirus in normal conditions [43]. There-
fore, one important question that remains unanswered is
whether MDV low titers are a consequence of a nuclear
egress defect. Taken into consideration that only 0.5% of
particles were mature enveloped virions in fibroblastic cells
in culture [26], the failure to detect such virions in tumor
cells was not totally surprising due to the low number of
total particles observed. To reduce animal experiments
and have an unlimited cells source, an interesting approach
would be to generate and use a lymphoid cell line estab-
lished from a MD tumor induced by a fluorescent virus,
which has no growth defect and expresses its fluorescent
tag exclusively during the lytic cycle.
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VP22 alters MDV replication in vivo in blood cells and
feathers as well as lymphoma induction and bird-to-bird
transmission showing that VP22 contributes to MDV
virulence. Although attenuated, this fluorescent virus al-
lows to select MD tumor cells in lytic cycle. Our work
demonstrates for a second time that the combination of
fluorescent MDV, recent imaging techniques, and TEM
provides new opportunities to examine MDV morpho-
genesis in various cell context, including harvested from
infected birds.
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